Literature DB >> 1549818

Acute severe deterioration in cystic fibrosis associated with influenza A virus infection.

S P Conway1, E J Simmonds, J M Littlewood.   

Abstract

BACKGROUND: The role of non-bacterial infection in respiratory exacerbations of cystic fibrosis has been studied less than that of bacterial infection. Some non-bacterial infections, such as influenza A, may be associated with acute respiratory deterioration and may be preventable. METHODS AND
RESULTS: Three patients with cystic fibrosis showed severe deterioration in lung function and general wellbeing during the influenza A virus epidemic in the winter of 1989-90. Serological confirmation of influenza A virus infection was obtained in each case.
CONCLUSIONS: As immunisation against influenza A virus is safe and provokes an adequate antibody response in patients with cystic fibrosis, it is concluded that patients with cystic fibrosis should be offered immunisation at the beginning of each influenza season. Rapid diagnostic tests and the use of antiviral drugs may have a prophylactic role in minimising lung damage.

Entities:  

Mesh:

Substances:

Year:  1992        PMID: 1549818      PMCID: PMC463587          DOI: 10.1136/thx.47.2.112

Source DB:  PubMed          Journal:  Thorax        ISSN: 0040-6376            Impact factor:   9.139


  15 in total

1.  Influenza vaccination in adults with cystic fibrosis.

Authors:  E L Ong; D Bilton; J Abbott; A K Webb; R A McCartney; E O Caul
Journal:  BMJ       Date:  1991-09-07

Review 2.  Prophylaxis and treatment of influenza.

Authors:  R G Douglas
Journal:  N Engl J Med       Date:  1990-02-15       Impact factor: 91.245

3.  Infective respiratory exacerbations in young adults with cystic fibrosis: role of viruses and atypical microorganisms.

Authors:  E L Ong; M E Ellis; A K Webb; K R Neal; M Dodd; E O Caul; S Burgess
Journal:  Thorax       Date:  1989-09       Impact factor: 9.139

4.  Bacterial-viral interrelations in respiratory infections of children.

Authors:  K P Nichol; J D Cherry
Journal:  N Engl J Med       Date:  1967-09-28       Impact factor: 91.245

5.  Viral and Mycoplasma pneumoniae infections in exacerbations of chronic lung disease.

Authors:  M J McNamara; I A Phillips; O B Williams
Journal:  Am Rev Respir Dis       Date:  1969-07

Review 6.  Viral infection in cystic fibrosis.

Authors:  J Stroobant
Journal:  J R Soc Med       Date:  1986       Impact factor: 5.344

7.  Microbial synergism in human infections (first of two parts).

Authors:  P A Mackowiak
Journal:  N Engl J Med       Date:  1978-01-05       Impact factor: 91.245

8.  Role of respiratory syncytial virus in early hospitalizations for respiratory distress of young infants with cystic fibrosis.

Authors:  S H Abman; J W Ogle; N Butler-Simon; C M Rumack; F J Accurso
Journal:  J Pediatr       Date:  1988-11       Impact factor: 4.406

9.  Respiratory infections in cystic fibrosis patients caused by virus, chlamydia and mycoplasma--possible synergism with Pseudomonas aeruginosa.

Authors:  N T Petersen; N Høiby; C H Mordhorst; K Lind; E W Flensborg; B Bruun
Journal:  Acta Paediatr Scand       Date:  1981-09

10.  Clinical manifestations of exacerbations of cystic fibrosis associated with nonbacterial infections.

Authors:  C G Pribble; P G Black; J A Bosso; R B Turner
Journal:  J Pediatr       Date:  1990-08       Impact factor: 4.406

View more
  17 in total

Review 1.  Recent advances in cross-infection in cystic fibrosis: Burkholderia cepacia complex, Pseudomonas aeruginosa, MRSA and Pandoraea spp.

Authors:  Andrew M Jones; A Kevin Webb
Journal:  J R Soc Med       Date:  2003       Impact factor: 5.344

2.  Viral infections: a role in the lung disease of cystic fibrosis?

Authors:  D J Shale
Journal:  Thorax       Date:  1992-02       Impact factor: 9.139

Review 3.  Spectrum of viral infections in patients with cystic fibrosis.

Authors:  H Frickmann; S Jungblut; T O Hirche; U Groß; M Kuhns; A E Zautner
Journal:  Eur J Microbiol Immunol (Bp)       Date:  2012-09-10

4.  Optimization of influenza vaccine delivery to high risk children and adolescents.

Authors: 
Journal:  Paediatr Child Health       Date:  1999-11       Impact factor: 2.253

5.  Influenza vaccination in children at high risk of respiratory disease.

Authors:  Maria Francesca Patria; Claudia Tagliabue; Benedetta Longhi; Susanna Esposito
Journal:  Ther Adv Vaccines       Date:  2013-05

6.  Pharmacokinetics and diffusion into sputum of oseltamivir and oseltamivir carboxylate in adults with cystic fibrosis.

Authors:  V Jullien; D Hubert; O Launay; G Babany; O Lortholary; I Sermet
Journal:  Antimicrob Agents Chemother       Date:  2011-06-13       Impact factor: 5.191

Review 7.  Vaccines for preventing influenza in people with cystic fibrosis.

Authors:  Poonam Dharmaraj; Rosalind L Smyth
Journal:  Cochrane Database Syst Rev       Date:  2014-03-06

8.  Ten years of viral and non-bacterial serology in adults with cystic fibrosis.

Authors:  I J Clifton; J A Kastelik; D G Peckham; A Hale; M Denton; C Etherington; S P Conway
Journal:  Epidemiol Infect       Date:  2007-03-12       Impact factor: 2.451

9.  Persistent oseltamivir-resistant pandemic influenza A/H1N1 infection in an adult with cystic fibrosis.

Authors:  William George Flight; Rowland Bright-Thomas; Kenneth Mutton; Kevin Webb; Andrew Jones
Journal:  BMJ Case Rep       Date:  2011-04-26

10.  The month of July: an early experience with pandemic influenza A (H1N1) in adults with cystic fibrosis.

Authors:  Megan W France; Szeanna Tai; Phillip J Masel; Vanessa L Moore; Tracy L McMahon; Alexander J Ritchie; Scott C Bell
Journal:  BMC Pulm Med       Date:  2010-02-25       Impact factor: 3.317

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.